Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 32.29 | 18.59 |
| PEG Ratio (TTM) | 6.03 | -0.09 |
| P/S Ratio (TTM) | 2.84 | 0.50 |
| P/B Ratio (TTM) | 6.37 | 1.31 |
| P/FCF Ratio (TTM) | 26.86 | 13.67 |
| Price to 5YR AVG Earnings Ratio | 167.30 | 14.50 |
| Price to 5YR AVG FCF Ratio | 706.22 | 56.62 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 14.51% | 4.16% |
| ROE (TTM) | 22.29% | 9.09% |
| Net Profit Margin (TTM) | 8.68% | 1.81% |
| ROIC 5YR AVG | 9.61% | 11.93% |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.12% | 32.00% | 389.92% |
| Revenue | 7.48% | 35.30% | 35.00% |
| Net Income | 38.68% | 16.81% | 389.12% |
| Cash Flow | 29.28% | 70.44% | 158.07% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.24 | 1.98 |
| Quick Ratio (TTM) | 2.81 | 1.16 |
| D/E Ratio (TTM) | N/A | 0.52 |
| Interest Coverage (TTM) | 57.35 | 4.08 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 13.93 | 3.76 |
| LTL to 5YR AVG FCF | 7.02 | 17.89 |
| Shares Outstanding Growth 5YR AVG | 5.30% | 0.95% |